Clinical Trials
Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services
Inceptua announced that Paul Wituschek has been appointed President North America. To further strengthen its position as a leading pharmaceutical company and service partner, Inceptua appoints Paul Wituschek as President North America effective 1 January, 2020.
Paul will take on...
News
UPM Raflatac to showcase its sustainable solutions for pharmaceutical and healthcare labeling at Pharmapack 2020
UPM Raflatac will showcase its leading range of sustainable labeling solutions for pharmaceutical and healthcare applications at the Pharmapack 2020 exhibition in Paris, held on February 5th–6th.
UPM Raflatac is strongly committed to sustainability and is working towards labeling a...
News
FedEx Assists Aid Organization Direct Relief to Transport its First Batch of Medical Supplies to Guangzhou, China
FedEx Express, the world’s largest express transportation company, has shipped more than 200,000 surgical masks and personal protective equipment such as gowns and gloves from the U.S. to assist the humanitarian work of Direct Relief. The shipment arrived at...
News
Pharmapack Europe unpacks key drivers and challenges in 2020
Pharmapack Europe (#pharmapackeu), organised by Informa Markets, has pinpointed a number of opportunities and threats that drug delivery and pharmaceutical packaging companies must address in 2020. The event, widely seen as Europe’s leading hub for the pharmaceutical packaging and...
IT & Data Management
Aptar Pharma Partners with Lupin to Launch India’s First Connected Smart Device for Respiratory Disease, ADHERO
Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, is pleased to announce that it has partnered with Lupin Limited to launch India’s first connected device for metered-dose inhalers (MDI) called ADHERO. This unique...
Clinical Trials
Epizyme Announces U.S. FDA Approval of TAZVERIK for the Treatment of Patients with Epithelioid Sarcoma
Epizyme, Inc., a biopharmaceutical company developing novel epigenetic therapies, announced that the U.S. FDA has granted accelerated approval of TAZVERIK for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid...
Drug Research
Predictive Oncology Acquire Quantitative Medicine and an AI Engine that Facilitates Accelerated Drug Discovery and Development
Predictive Oncology Inc , a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, announces it has signed a letter of intent to acquire Quantitative Medicine.
Dr. Carl Schwartz, president and CEO of Predictive Oncology, believes...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read